Development of 5-Fluorouracil Derivatives as Anticancer Agents

Title: Development of 5-Fluorouracil Derivatives as Anticancer Agents

Volume: 18 Issue: 29

Author(s): Xiaoyan Pan, Chen Wang, Fang Wang, Pengfei Li, Zhigang Hu, Yuanyuan Shan and Jie Zhang

Affiliation:

Keywords: 5-Fluorouracil (5-FU), anticancer, thymidylate synthase, antimetabolite, toxicity, tumor, derivative, macromolecule, pyrimidine, polymer

Abstract: 5-Fluorouracil (5-FU) is one of the most potent antimetabolites which have been widely used in the treatment of advanced solid tumors. As an anticancer agent, because of its low efficacy and high toxicity, numerous modifications of 5-FU structure have been performed. A great number of novel 5-FU derivatives have been developed with highly efficient and much less toxic. In this paper, the recent development of novel 5-FU derivatives as potent antitumor agents is reviewed and discussed.

Cite this article as:

Pan Xiaoyan, Wang Chen, Wang Fang, Li Pengfei, Hu Zhigang, Shan Yuanyuan and Zhang Jie, Development of 5-Fluorouracil Derivatives as Anticancer Agents, Current Medicinal Chemistry 2011; 18 (29) . https://dx.doi.org/10.2174/092986711797287584